BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dizon ML, Maa T, Kessler JA. The bone morphogenetic protein antagonist noggin protects white matter after perinatal hypoxia-ischemia. Neurobiol Dis 2011;42:318-26. [PMID: 21310236 DOI: 10.1016/j.nbd.2011.01.023] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Zhang G, Ge M, Han Z, Wang S, Yin J, Peng L, Xu F, Zhang Q, Dai Z, Xie L, Li Y, Si J, Ma K. Wnt/β-catenin signaling pathway contributes to isoflurane postconditioning against cerebral ischemia-reperfusion injury and is possibly related to the transforming growth factorβ1/Smad3 signaling pathway. Biomedicine & Pharmacotherapy 2019;110:420-30. [DOI: 10.1016/j.biopha.2018.11.143] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
2 van Tilborg E, de Theije CGM, van Hal M, Wagenaar N, de Vries LS, Benders MJ, Rowitch DH, Nijboer CH. Origin and dynamics of oligodendrocytes in the developing brain: Implications for perinatal white matter injury. Glia 2018;66:221-38. [PMID: 29134703 DOI: 10.1002/glia.23256] [Cited by in Crossref: 82] [Cited by in F6Publishing: 84] [Article Influence: 16.4] [Reference Citation Analysis]
3 Zhang R, Zhang Z, Chopp M. Function of neural stem cells in ischemic brain repair processes. J Cereb Blood Flow Metab 2016;36:2034-43. [PMID: 27742890 DOI: 10.1177/0271678X16674487] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
4 Chang J, Dettman RW, Dizon MLV. Bone morphogenetic protein signaling: a promising target for white matter protection in perinatal brain injury. Neural Regen Res 2018;13:1183-4. [PMID: 30028321 DOI: 10.4103/1673-5374.235025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
5 Hart CG, Karimi-Abdolrezaee S. Bone morphogenetic proteins: New insights into their roles and mechanisms in CNS development, pathology and repair. Exp Neurol 2020;334:113455. [PMID: 32877654 DOI: 10.1016/j.expneurol.2020.113455] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
6 Sabo JK, Heine V, Silbereis JC, Schirmer L, Levison SW, Rowitch DH. Olig1 is required for noggin-induced neonatal myelin repair. Ann Neurol 2017;81:560-71. [PMID: 28253550 DOI: 10.1002/ana.24907] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
7 Joseph-Pauline S, Morrison N, Braccia M, Payne A, Gugerty L, Mostoller J, Lecker P, Tsai EJ, Kim J, Martin M, Brahmbhatt R, Gorski G, Gerhart J, George-Weinstein M, Stone J, Purushothuman S, Bravo-Nuevo A. Acute Response and Neuroprotective Role of Myo/Nog Cells Assessed in a Rat Model of Focal Brain Injury. Front Neurosci 2021;15:780707. [PMID: 34949984 DOI: 10.3389/fnins.2021.780707] [Reference Citation Analysis]
8 Grinspan JB. Bone Morphogenetic Proteins. Bone Morphogenic Protein. Elsevier; 2015. pp. 195-222. [DOI: 10.1016/bs.vh.2015.05.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
9 Grinspan JB. Inhibitors of Myelination and Remyelination, Bone Morphogenetic Proteins, are Upregulated in Human Neurological Disease. Neurochem Res 2020;45:656-62. [PMID: 32030597 DOI: 10.1007/s11064-020-02980-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Motavaf M, Piao X. Oligodendrocyte Development and Implication in Perinatal White Matter Injury. Front Cell Neurosci 2021;15:764486. [PMID: 34803612 DOI: 10.3389/fncel.2021.764486] [Reference Citation Analysis]
11 Sabo JK, Cate HS. Signalling pathways that inhibit the capacity of precursor cells for myelin repair. Int J Mol Sci 2013;14:1031-49. [PMID: 23296277 DOI: 10.3390/ijms14011031] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
12 Uemura MT, Ihara M, Maki T, Nakagomi T, Kaji S, Uemura K, Matsuyama T, Kalaria RN, Kinoshita A, Takahashi R. Pericyte-derived bone morphogenetic protein 4 underlies white matter damage after chronic hypoperfusion. Brain Pathol 2018;28:521-35. [PMID: 28470822 DOI: 10.1111/bpa.12523] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
13 Chen XS, Zhang YH, Cai QY, Yao ZX. ID2: A negative transcription factor regulating oligodendroglia differentiation. J Neurosci Res 2012;90:925-32. [PMID: 22253220 DOI: 10.1002/jnr.22826] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
14 Shijo T, Warita H, Suzuki N, Ikeda K, Mitsuzawa S, Akiyama T, Ono H, Nishiyama A, Izumi R, Kitajima Y, Aoki M. Antagonizing bone morphogenetic protein 4 attenuates disease progression in a rat model of amyotrophic lateral sclerosis. Exp Neurol 2018;307:164-79. [PMID: 29932880 DOI: 10.1016/j.expneurol.2018.06.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
15 Vaes JEG, Brandt MJV, Wanders N, Benders MJNL, de Theije CGM, Gressens P, Nijboer CH. The impact of trophic and immunomodulatory factors on oligodendrocyte maturation: Potential treatments for encephalopathy of prematurity. Glia 2021;69:1311-40. [PMID: 33595855 DOI: 10.1002/glia.23939] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Ogawa Y, Tsuji M, Tanaka E, Miyazato M, Hino J. Bone Morphogenetic Protein (BMP)-3b Gene Depletion Causes High Mortality in a Mouse Model of Neonatal Hypoxic-Ischemic Encephalopathy. Front Neurol 2018;9:397. [PMID: 29922215 DOI: 10.3389/fneur.2018.00397] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Takagi T, Yoshimura S, Sakuma R, Nakano-Doi A, Matsuyama T, Nakagomi T. Novel Regenerative Therapies Based on Regionally Induced Multipotent Stem Cells in Post-Stroke Brains: Their Origin, Characterization, and Perspective. Transl Stroke Res. 2017;8:515-528. [PMID: 28744717 DOI: 10.1007/s12975-017-0556-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
18 van Tilborg E, Heijnen CJ, Benders MJ, van Bel F, Fleiss B, Gressens P, Nijboer CH. Impaired oligodendrocyte maturation in preterm infants: Potential therapeutic targets. Prog Neurobiol 2016;136:28-49. [PMID: 26655283 DOI: 10.1016/j.pneurobio.2015.11.002] [Cited by in Crossref: 69] [Cited by in F6Publishing: 64] [Article Influence: 9.9] [Reference Citation Analysis]
19 Huang Y, Wang X, Lin H. The hypoxic microenvironment: a driving force for heterotopic ossification progression. Cell Commun Signal 2020;18:20. [PMID: 32028956 DOI: 10.1186/s12964-020-0509-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Ulanska-Poutanen J, Mieczkowski J, Zhao C, Konarzewska K, Kaza B, Pohl HB, Bugajski L, Kaminska B, Franklin RJ, Zawadzka M. Injury-induced perivascular niche supports alternative differentiation of adult rodent CNS progenitor cells. Elife 2018;7:e30325. [PMID: 30222103 DOI: 10.7554/eLife.30325] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
21 El Waly B, Macchi M, Cayre M, Durbec P. Oligodendrogenesis in the normal and pathological central nervous system. Front Neurosci. 2014;8:145. [PMID: 24971048 DOI: 10.3389/fnins.2014.00145] [Cited by in Crossref: 87] [Cited by in F6Publishing: 82] [Article Influence: 10.9] [Reference Citation Analysis]
22 Heinonen AM, Rahman M, Dogbevia G, Jakobi H, Wölfl S, Sprengel R, Schwaninger M. Neuroprotection by rAAV-mediated gene transfer of bone morphogenic protein 7. BMC Neurosci 2014;15:38. [PMID: 24618040 DOI: 10.1186/1471-2202-15-38] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
23 Chew LJ, DeBoy CA. Pharmacological approaches to intervention in hypomyelinating and demyelinating white matter pathology. Neuropharmacology 2016;110:605-25. [PMID: 26116759 DOI: 10.1016/j.neuropharm.2015.06.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
24 Li Q, Lou J, Yang T, Wei Z, Li S, Zhang F. Ischemic Preconditioning Induces Oligodendrogenesis in Mouse Brain: Effects of Nrf2 Deficiency. Cell Mol Neurobiol 2021. [PMID: 33666795 DOI: 10.1007/s10571-021-01068-5] [Reference Citation Analysis]
25 Choe Y, Huynh T, Pleasure SJ. Migration of oligodendrocyte progenitor cells is controlled by transforming growth factor β family proteins during corticogenesis. J Neurosci 2014;34:14973-83. [PMID: 25378163 DOI: 10.1523/JNEUROSCI.1156-14.2014] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
26 Dettman RW, Birch D, Fernando A, Kessler JA, Dizon MLV. Targeted Knockdown of Bone Morphogenetic Protein Signaling within Neural Progenitors Protects the Brain and Improves Motor Function following Postnatal Hypoxia-Ischemia. Dev Neurosci 2018;40:23-38. [PMID: 29324456 DOI: 10.1159/000485379] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
27 Gou X, Tang Y, Qu Y, Xiao D, Ying J, Mu D. Could the inhibitor of DNA binding 2 and 4 play a role in white matter injury? Reviews in the Neurosciences 2019;30:625-38. [DOI: 10.1515/revneuro-2018-0090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Zeng Y, Wang H, Zhang L, Tang J, Shi J, Xiao D, Qu Y, Mu D. The optimal choices of animal models of white matter injury. Rev Neurosci 2019;30:245-59. [PMID: 30379639 DOI: 10.1515/revneuro-2018-0044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Tolcos M, Petratos S, Hirst JJ, Wong F, Spencer SJ, Azhan A, Emery B, Walker DW. Blocked, delayed, or obstructed: What causes poor white matter development in intrauterine growth restricted infants? Prog Neurobiol 2017;154:62-77. [PMID: 28392287 DOI: 10.1016/j.pneurobio.2017.03.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
30 Shin JA, Kim YA, Kim HW, Kim HS, Lee KE, Kang JL, Park EM. Iron released from reactive microglia by noggin improves myelin repair in the ischemic brain. Neuropharmacology 2018;133:202-15. [PMID: 29407213 DOI: 10.1016/j.neuropharm.2018.01.038] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
31 Wheeler NA, Fuss B. Extracellular cues influencing oligodendrocyte differentiation and (re)myelination. Exp Neurol 2016;283:512-30. [PMID: 27016069 DOI: 10.1016/j.expneurol.2016.03.019] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 6.3] [Reference Citation Analysis]
32 Bowyer JF, Patterson TA, Saini UT, Hanig JP, Thomas M, Camacho L, George NI, Chen JJ. Comparison of the global gene expression of choroid plexus and meninges and associated vasculature under control conditions and after pronounced hyperthermia or amphetamine toxicity. BMC Genomics 2013;14:147. [PMID: 23497014 DOI: 10.1186/1471-2164-14-147] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
33 Wang S, Yin J, Ge M, Dai Z, Li Y, Si J, Ma K, Li L, Yao S. Transforming growth-beta 1 contributes to isoflurane postconditioning against cerebral ischemia-reperfusion injury by regulating the c-Jun N-terminal kinase signaling pathway. Biomed Pharmacother 2016;78:280-90. [PMID: 26898453 DOI: 10.1016/j.biopha.2016.01.030] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
34 Reid MV, Murray KA, Marsh ED, Golden JA, Simmons RA, Grinspan JB. Delayed myelination in an intrauterine growth retardation model is mediated by oxidative stress upregulating bone morphogenetic protein 4. J Neuropathol Exp Neurol. 2012;71:640-653. [PMID: 22710965 DOI: 10.1097/nen.0b013e31825cfa81] [Cited by in Crossref: 64] [Cited by in F6Publishing: 47] [Article Influence: 6.4] [Reference Citation Analysis]
35 Wang H, Lindborg C, Lounev V, Kim JH, McCarrick-Walmsley R, Xu M, Mangiavini L, Groppe JC, Shore EM, Schipani E, Kaplan FS, Pignolo RJ. Cellular Hypoxia Promotes Heterotopic Ossification by Amplifying BMP Signaling. J Bone Miner Res 2016;31:1652-65. [PMID: 27027798 DOI: 10.1002/jbmr.2848] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 11.7] [Reference Citation Analysis]